MINI REVIEW ARTICLE
Year : 2021 | Volume
: 14 | Issue : 1 | Page : 22--30
Prostate-Specific antigen: An overview and its current status in the diagnosis of prostate cancer
Siddalingeshwar Neeli, Manas Sharma, Abhijit Musale Department of Urology, KLE Academy of Higher Education and Research (Deemed-to-be-University), Belagavi, Karnataka, India
Correspondence Address:
Dr. Siddalingeshwar Neeli Department of Urology, KLE Academy of Higher Education and Research (Deemed-to-be-University), JNMC Campus, Belagavi - 590 010, Karnataka India
Prostate-Specific Antigen (PSA), which has high organ specificity and poor cancer specificity, has been widely utilized for the diagnosis and treatment of prostate cancer; though it is not an ideal tumor marker. Its extensive usage in screening programs has resulted in a large number of unwanted biopsies, over-diagnosis and over-treatment of indolent cancers as well. Hence, various PSA derivatives and PSA-based tests have evolved to improve the accuracy of prostate cancer diagnosis. This article provides an overview of PSA and PSA-based biomarkers and their current role in the screening and diagnosis of prostate cancer.
How to cite this article:
Neeli S, Sharma M, Musale A. Prostate-Specific antigen: An overview and its current status in the diagnosis of prostate cancer.Indian J Health Sci Biomed Res 2021;14:22-30
|
How to cite this URL:
Neeli S, Sharma M, Musale A. Prostate-Specific antigen: An overview and its current status in the diagnosis of prostate cancer. Indian J Health Sci Biomed Res [serial online] 2021 [cited 2021 Apr 23 ];14:22-30
Available from: https://www.ijournalhs.org/article.asp?issn=2542-6214;year=2021;volume=14;issue=1;spage=22;epage=30;aulast=Neeli;type=0 |
|
|